The American Heart Association (AHA) and the American Diabetes Association (ADA) has announced the start of a new multi-...
Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of new evidence that Cose...
Seema Kumar, Vice President of Innovation, Global Health and Science Policy Communication for Johnson & Johnson was ...
MedUni Vienna has developed a method that can be used to identify individual rhinovirus strains ("cold viruses") as a ca...
Global pharmaceutical company Mylan has announced the US launch of Bivalirudin for Injection, 250 mg singl...
An international team of researchers has developed a new minimally invasive medical device called Therepi that can be pl...
Life Sciences informatics company Benchling said that it closed a $14.5 million Series B round of venture capital. Bench...
The 2018 BIO International Convention (BIO 2018) recently wrapped up four days of programming under the theme ...
TiGenix, an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or ...
Over the past several years, HIV researchers have identified many broadly neutralizing antibodies that can protect human...
Vergent Bioscience, a cancer-focused biotechnology company has announced that it raised $8.7 million in a Series A finan...
Singapore- Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins, announced that Ha...
Singapore- Artelo Biosciences, a biopharmaceutical company focused on the development of therapeutic treatments that mod...
Singapore- The New Brunswick, NJ-based company recently reported that it has accepted Platinum Equity's $2.1 billi...
DNA testing companies like 23andMe and Ancestry.com are being investigated by the Federal Trade Commission over their po...
Juvenescence Limited, a leader in the development of therapies to slow, halt or potentially reverse aging, has successfu...
Singapore – Aimmune Therapeutics, a biopharmaceutical company developing treatments for potentially life-threateni...
Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transfor...
